Liposomal Encapsulation Reduces Hemolysis and Systemic Toxicity of Sea Cucumber-Derived Echinoside A for Breast Cancer Treatment
Advanced Functional Foods · 2026
DOI: 10.64187/aff.2026.v2.i3.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Foods, 2026. Verfasst von Chuqiao Zhang und 6 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qingdao Natural Science Foundation, Postdoctoral Innovation Program of Shandong Province.
Abstract (Originalsprache)
Sea cucumber saponins exhibit potent antitumor bioactivity, yet their severe hemolytic toxicity greatly restricts their further exploration in antitumor delivery research. In this study, Echinoside A (EA), a triterpene glycoside isolated from Pearsonothuria graeffei, was encapsulated within liposomes to alleviate the inherent hemolytic risk of free EA. Physicochemical characterization revealed that the fabricated EA-loaded liposomes (EA@Lipo) displayed a regular spherical morphology, with an average particle size of 35.6 ± 3.6 nm and a zeta potential of –10.2 ± 0.25 mV. The entrapment efficiency and drug loading capacity of EA were determined to be 99.0% and 9.0%, respectively. Compared with free EA, EA@Lipo exhibited a remarkably low hemolysis rate of only 3.6% even at a high concentration of 800 μg/mL, demonstrating greatly improved biosafety. The formulation remained stable under physiological pH conditions, which reflected strong intermolecular binding between EA and lipid components. Cellular assays confirmed that EA@Lipo was internalized into MDA-MB-231 cells through energy-dependent endocytosis and suppressed cell proliferation by inducing apoptosis and cell cycle arrest. In vivo experimental results further demonstrated that EA@Lipo inhibited tumour progression by regulating the PI3K/Akt pathway. No obvious body weight loss was observed in treated mice, confirming its favourable in vivo biocompatibility. Collectively, these findings suggest that EA@Lipo represents a feasible liposomal delivery strategy for breast cancer research. This nanoformulation effectively relieves the hemolytic toxicity of free EA and provides an experimental basis for the exploration of marine saponin-based antitumor delivery systems.
Förderung
- Qingdao Natural Science Foundation
- Postdoctoral Innovation Program of Shandong Province
Zitieren
APA
Zhang, C., Yang, L., Cui, H., Cong, P., Ke, X., Xue, C., & Li, H. (2026). Liposomal Encapsulation Reduces Hemolysis and Systemic Toxicity of Sea Cucumber-Derived Echinoside A for Breast Cancer Treatment. Advanced Functional Foods. https://doi.org/10.64187/aff.2026.v2.i3.003
Vancouver
Zhang C, Yang L, Cui H, Cong P, Ke X, Xue C, et al. Liposomal Encapsulation Reduces Hemolysis and Systemic Toxicity of Sea Cucumber-Derived Echinoside A for Breast Cancer Treatment. Advanced Functional Foods. 2026. doi:10.64187/aff.2026.v2.i3.003
BibTeX
@article{Zhang2026,
author = {Zhang, Chuqiao and Yang, Lu and Cui, Huanhuan and Cong, Peixu and Ke, Xiao and Xue, Changhu and Li, Hongyan},
title = {Liposomal Encapsulation Reduces Hemolysis and Systemic Toxicity of Sea Cucumber-Derived Echinoside A for Breast Cancer Treatment},
journal = {Advanced Functional Foods},
year = {2026},
doi = {10.64187/aff.2026.v2.i3.003}
}
EUVIMED